QCM Cayman’s DexCom DXCM Stock Holding History

QCM Cayman’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,672	Closed	-$214K	–	50
2022 Q1	$214K	Buy	+1,672	New	+$183K	0.94%	56
2021 Q1	–	Sell	-2,728	Closed	-$252K	–	153
2020 Q4	$252K	Buy	+2,728	New	+$244K	0.26%	155
2014 Q2	–	Sell	-21,508	Closed	-$222K	–	266
2014 Q1	$222K	Buy	+21,508	New	+$222K	0.05%	239

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QCM Cayman's DXCM Position: Q2 2022 in Review

QCM Cayman sold out of DexCom (DXCM) in Q2 2022, closing a stake of 1,672 shares — an estimated $214K sold.

QCM Cayman first reported a position in DXCM in Q1 2014 and held it in 3 quarters. The position peaked at $252K in Q4 2020. 797 funds tracked by Wall St. Rank hold DXCM as of Q2 2022.

QCM Cayman reported no remaining DexCom position as of Q2 2022 after selling out during the quarter.
QCM Cayman sold 1,672 DexCom shares in Q2 2022, an estimated $214K.
QCM Cayman first reported a position in DexCom in Q1 2014 and held it in 3 quarters.
QCM Cayman's DexCom position peaked at $252K in Q4 2020.
797 funds tracked by Wall St. Rank held DexCom as of Q2 2022.

Based on QCM Cayman's 13F filing for Q2 2022, filed 27 Jul 2022.